The Myaderm offering is now closed and is no longer accepting investments.

Myaderm

Revolutionizing Pain Relief & Skin Care with CBD

Myaderm

Revolutionizing Pain Relief & Skin Care with CBD

Centennial, CO
Consumer Products
Retail
Myaderm is revolutionizing how you look and feel. The revolution started in 2017 with innovative cannabidiol (CBD) products that deliver effective results. Today, as a leading brand distributed coast to coast, we continue our commitment to dramatically improve how you look and feel.

$42,998

raised
53
Investors
$24.9M
Valuation
$2.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left

$42,998

raised
53
Investors
$24.9M
Valuation
$2.00
Price per Share
$250.00
Min. Investment
Common
Shares Offered
Equity
Offering Type
$1.07M
Offering Max
0
Days Left
This offering ended on September 16, 2022 and is no longer accepting investments.

Reasons to Invest

Over three years sold coast to coast through national retailers like GNC, Rite Aid, Dick’s Sporting Goods, Golf Galaxy, 7-Eleven.
Myaderm is the only CBD brand sold through national retailers that is FDA compliant.
The US skin care market size is $18 billion and the US topical pain relief market size is $3 billion.*

*Market statistics provided by Statista (sourcesource)

Revolutionizing how you look and feel

Myaderm formulates, develops, manufactures, and sells skin care and pain relief products that utilize CBD as a key ingredient. We sell our products through national and local retailers, as well as directly to customers through our website. We provide products with proven pharmaceutical technologies that deliver results


We are committed to providing the most compelling value in the market with minimized or no price friction for customers. Our mission is to revolutionize how people look and feel through the latest innovations in ingredients and technologies.


The Problem


CBD products that have low concentrations and lack technologies don’t deliver 

There is a significant amount of confusion and misinformation about topical CBD products. The primary problem is with brands that rely on other well known ingredients (e.g. menthol, lidocaine) to get an effect. Those topical products also have incredibly low concentrations of CBD and lack any capable technologies (e.g. transdermal delivery, emulsification) that allow CBD to deliver results.


The Solution


Myaderm uses CBD and pharmaceutical technologies for fast acting relief and clear results


Pain Relief Competitive Advantages:

  • Transdermal: drives CBD into muscle and connective tissue.
  • Non-greasy and fast absorbing: other brands use oil-bases to hold CBD.
  • Emulsification: high concentration of CBD in a water-bases.
  • In-house formulation and manufacturing: does not utilize contract manufacturers with stock formulas.



Skin Care Competitive Advantages:

  • Gel-Cream technology that is non-greasy and fast absorbing: other brands use oil-bases to hold CBD.
  • Key Ingredients paired with CBD: Hyaluronic Acid, Pro-Retinol.
  • Emulsification: high concentration of CBD in a water-bases.
  • In-house formulation and manufacturing: does not utilize contract manufacturers with stock formulas.



INNOVATIVE

Industry leading IP and pharmaceutical technologies utilized in all products. We do not use contract manufacturers with stock formulas.


SCALABLE

Cost reduction and quality control with internal manufacturing and fulfillment expertise. We manufacture and formulate all products.


GLOBAL

FDA compliant and therapeutic products create rapid and sustainable sales.

The Market


The only CBD brand sold through national retailers that is FDA compliant

(source)


Skin care, as a market segment, is growing faster than any other part of the beauty industry. Sales of skincare products grew by 13% last year in the United States, while makeup grew by only 1% in the same period. Online beauty retailers grew 24% in that time, with skincare leading the way. (source)



Within the topical pain relief category, the rising incidences of arthritis, joint pain, and diabetic neuropathy is driving the industry growth. The growing geriatric population in the US is providing further impetus to the industry. Fewer side effects induced by topical pain relief related to oral medicine is driving the industry forward. Greater accessibility and growing awareness of topical pain medications are further aiding the industry growth.


(source)

Our Traction


Nationally distributed & selling online

Myaderm has succeeded at the national level with coast to coast sales through national retailers like GNC, Rite Aid, Dick’s Sporting Goods, Golf Galaxy, 7-Eleven.


*This testimonial may not be representative of the experience of other customers and is not a guarantee of future performance or success.


Why Invest


Welcome to revolution in pain relief and skin care

We are dedicated to being leaders in the skin care and pain relief markets to revolutionize how people look and feel.



Code View

Offering Summary


Company

:

Myaderm, Inc.

Corporate Address

:

9200 E. Mineral Avenue, Ste. 355, Centennial, CO 80112

Offering Minimum

:

$10,000.00

Offering Maximum

:

$1,069,998.00

Minimum Investment Amount

(per investor)

:

$250.00











Terms


Offering Type

:

Equity

Security Name

:

Common Stock

Minimum Number of Shares Offered

:

5,000

Maximum Number of Shares Offered

:

534,999

Price per Share

:

$2.00

Pre-Money Valuation

:

$24,883,884.00











Voting Rights of Securities Sold in this Offering

Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock.


*Maximum Number of Shares Offered subject to adjustment for bonus shares. See Bonus info below.

Investment Incentives*

Time-Based:

Early Bird

Invest within the first two weeks and receive an additional 10% bonus shares.

Amount-Based

$250+
Advanced Therapy Fast Acting Relief Cream 1.7oz. ($49.99 retail value)

$500+
Advanced RX Fast Acting Relief Cream RX10 1.7oz. ($79.99 retail value)

$1,000+
3 Advanced RX Fast Acting Relief Cream RX20 1.7oz. ($299.97 retail value) 

$2,000+
3 Advanced RX Fast Acting Relief Cream RX20 1.7oz., 1 Ultimate Hydration Facial Moisturizer 1.7oz., 1 Ultimate Calming Cream 1.7oz and 1 Ultimate Wrinkle Repair 1.7oz. Set. ($374.94 retail value)

$5,000+

10 Products of choice (up to $999.99 retail value)

$10,000+

20 Products of choice (up to $1,999.80 retail value)

*All perks occur when the offering is completed.

The 10% StartEngine OWNers' Bonus

Myaderm will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.

This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $2.00 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $200. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.

This 10% Bonus is only valid during the investor's eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.

Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus.

The Company will not incur any irregular use of proceeds.


Show More
Most recent fiscal year-end:
Prior fiscal year-end:
Total Assets
$2,787,567.00 USD
$3,057,868.00 USD
Cash And Cash Equivalents
$137,128.00 USD
$42,856.00 USD
Accounts Receivable
$548,806.00 USD
$662,280.00 USD
Short Term Debt
$196,431.00 USD
$874,582.00 USD
Long Term Debt
$1,645,262.00 USD
$1,620,230.00 USD
Revenues And Sales
$1,748,679.00 USD
$1,787,846.00 USD
Costs Of Goods Sold
$391,166.00 USD
$515,391.00 USD
Taxes Paid
-$77,365.00 USD
$418,920.00 USD
Net Income
$382,820.00 USD
-$1,137,224.00 USD

Risks

A crowdfunding investment involves risk. You should not invest any funds in this offering unless you can afford to lose your entire investment. In making an investment decision, investors must rely on their own examination of the issuer and the terms of the offering, including the merits and risks involved. These securities have not been recommended or approved by any federal or state securities commission or regulatory authority. Furthermore, these authorities have not passed upon the accuracy or adequacy of this document. The U.S. Securities and Exchange Commission does not pass upon the merits of any securities offered or the terms of the offering, nor does it pass upon the accuracy or completeness of any offering document or literature. These securities are offered under an exemption from registration; however, the U.S. Securities and Exchange Commission has not made an independent determination that these securities are exempt from registration.


Updates

Only 12 Hours Left to Invest!

22 days ago

There are only 12 Hours Left to Invest!

 

Counting down the last 12 Hours until this offering closes on StartEngine!

 

We’re looking forward to sharing our next goals with you, so please make sure you join our mailing list. Sign Up!

 

You can still invest today (Thursday, September 15, 2022) but it must be before 11:59 PM PST (tonight).

Only 24 Hours Left to Invest!

23 days ago

There is Only 1 day Left to Invest!

 

Counting down the last 24 hours until our current offering closes on StartEngine!

 

We have some exciting plans moving forward, so make sure you join our mailing list for updates.

 

You can still invest before Thursday September 15th at 11:59 PM PST


48 Hours Until Our Campaign Closes!

24 days ago

Thank you for your support and belief!

 

We’re committed to building the future of skin care and pain relief using cannabidiol (CBD) as a key ingredient.

 

If you love an active lifestyle and great skin like us, and believe in the innovation and excitement of transdermal CBD, then we are the investment for you!

Join Our Webinar on Wednesday September 14th to Hear CEO and Founder, Eric Smart Speak

25 days ago

On Wednesday September 14th at 2pm EST, Myaderm will be hosting a webinar

 

Hello current and future investors,

Please join this webinar to hear from CEO and Founder, Eric Smart as he gives company updates before our campaign ends on Thursday September 15th. Find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm.

You should take advantage of this FREE webinar to find out how to invest, before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 1234

We encourage everyone to spread the word and about this online event.

Only 1 Week Left for our StartEngine Campaign!

29 days ago

Our campaign on StartEngine will officially close in 7 days. So, click the green Invest Now button at the top right-hand side of the page today! And once again, to all our investors who have helped get us this far. THANK YOU

 

Myaderm manufactures and distributes effective skin care and pain relief products using cannabidiol (CBD) as a key ingredient. Myaderm manufactures the only nationally sold FDA-compliant portfolio of CBD products and all products contain pure CBD (no THC) from American industrial hemp sources.


Only 9 Days Left to Invest!

about 1 month ago


We’re getting close to completing our current offering, and there are now only 9 days left until the offering closes on StartEngine!

We want to thank you for your support. Together we will revolutionize the way you look and feel.

If you are still considering investing or upping your current investment in Myaderm, today is the day!


Only Two Weeks Left to Invest in Myaderm on StartEngine!

about 1 month ago

We’re on-the-clock for counting down to the offer closing date of September 15, 2022.

 

Join our investor family, have confidence in how we are revolutionizing the way you look and feel, manufacturing and distributing effective skin care and pain relief products using cannabidiol (CBD) as a key ingredient. Myaderm manufactures the only nationally sold FDA-compliant portfolio of CBD products and all products contain pure CBD (no THC) from American industrial hemp sources.

 

Right now is the perfect time for you to make your best decision of the day (if not the week, month and year!) You are here at our StartEngine investment page reading this update, just scroll up to the top and hit Invest Now. Questions? We have answers. Share them with us in the comments section.


Reminder: Join Us for Our Investor Event with CEO and Founder, Eric Smart

about 1 month ago


On Thursday August 25th at 1pm EST, Myaderm will be hosting a webinar

Hello current and future investors,

This event is an exclusive opportunity to hear from CEO and Founder, Eric Smart as he gives company updates and speaks to our UPCOMING marketing efforts. Find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm.

You should take advantage of this FREE webinar to find out how to invest, before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 1234

We encourage everyone to spread the word and about this online event.

Join Us for Our Investor Event with CEO and Founder, Eric Smart

about 2 months ago

On Thursday August 25th at 1pm EST, Myaderm will be hosting a webinar

 

Hello current and future investors,

This event is an exclusive opportunity to hear from CEO and Founder, Eric Smart as he gives company updates and speaks to our UPCOMING marketing efforts. Find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm.

You should take advantage of this FREE webinar to find out how to invest, before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 1234

We encourage everyone to spread the word and about this online event.

Join Our Webinar Today 1pm EST to Find Out More About Going Public

2 months ago

Join Our Webinar on Wednesday July 27th to Find Out More About Going Public!

2 months ago

Mark Your Calendar: Webinar with CEO and Founder, Eric Smart

3 months ago

 

On Wednesday July 27th at 1pm EST, Myaderm will will be doing a webinar

 

Hello current and future Myaderm investors,

We’ll be turning the camera on for our CEO and founder, Eric Smart to find out how Myaderm is building the most successful brand using CBD as a key ingredient. He’ll answer any questions you may have about investing and share all the exciting things happening at Myaderm

You should take advantage of this FREE webinar to find out how to invest before Myaderm goes public. 

You can register for the webinar on Zoom here. Passcode: 075302

We encourage everyone to spread the word and about this online event.

More Reasons to Invest:

3 months ago

 ⁃ Sustained Success: $11 million in lifetime sales

 ⁃ Strong Investor Community: $2 million raised from accredited investors

 ⁃ Proven Pharmaceutical Technologies: transdermal delivery of CBD that effectively reduces inflammation and pain. 


Myaderm is a profitable brand that is leading in the pain relief and skin care markets using CBD as key ingredient. We deliver proven pharmaceutical technologies in products that dramatically improve how you look and feel.

Let Us Know What You Think

3 months ago

Myaderm has deals on the table with a Major League Baseball team and the recently formed Major League Rugby. Would love to hear from investors and anyone interested in Myaderm which sounds more compelling and interesting. Should we partner with one or the other or both? This is one example of why we are raising capital!

Only five days left for our Early Bird Offer

3 months ago

Why not earn an extra 10% of shares? Why wait on the sidelines? Invest now and earn an extra 10%. This offer will expire on Tuesday morning 10AM eastern time. 

Myaderm, a Market Leader in CBD Products, Raising Capital to Drive Growth Through StartEngine Launch

4 months ago

Welcome Myaderm Investors

4 months ago

We are excited for you to become an investor in Myaderm and part of the team! Over the past four years we’ve disrupted the topical relief and skin care markets using CBD as a key ingredient. Myaderm is now raising capital to drive growth and market leadership. We make innovative products that use proven pharmaceutical technologies to deliver results. Our mission is clear: revolutionize how you look and feel. - Eric Smart, CEO and Founder of Myaderm.

Show More Updates End of Updates

Comments ({{profileCtrl.startup.comments_count}} total)

{{profileCtrl.newComment.body.length}}/2500
Please sign in to post a comment.
Please use Updates for communications.
{{ profileCtrl.commentsLoading ? 'Loading...' : 'Show More Comments' }}